BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

622 related articles for article (PubMed ID: 27681974)

  • 1. Barrett's oesophagus: epidemiology, diagnosis and clinical management.
    Whiteman DC; Kendall BJ
    Med J Aust; 2016 Oct; 205(7):317-24. PubMed ID: 27681974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barrett's oesophagus: Current controversies.
    Amadi C; Gatenby P
    World J Gastroenterol; 2017 Jul; 23(28):5051-5067. PubMed ID: 28811703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Helicobacter pylori infection in 160 patients with Barrett's oesophagus or Barrett's adenocarcinoma.
    Lord RV; Frommer DJ; Inder S; Tran D; Ward RL
    Aust N Z J Surg; 2000 Jan; 70(1):26-33. PubMed ID: 10696939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.
    Garside R; Pitt M; Somerville M; Stein K; Price A; Gilbert N
    Health Technol Assess; 2006 Mar; 10(8):1-142, iii-iv. PubMed ID: 16545207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should patients with Barrett's oesophagus be kept under surveillance? The case for.
    Armstrong D
    Best Pract Res Clin Gastroenterol; 2008; 22(4):721-39. PubMed ID: 18656826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and treatment of Barrett's oesophagus. A general survey.
    Petrakis IE; Sciacca V; Iascone C
    Acta Chir Belg; 2001; 101(2):53-8. PubMed ID: 11396051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Length of Barrett's oesophagus and cancer risk: implications from a large sample of patients with early oesophageal adenocarcinoma.
    Pohl H; Pech O; Arash H; Stolte M; Manner H; May A; Kraywinkel K; Sonnenberg A; Ell C
    Gut; 2016 Feb; 65(2):196-201. PubMed ID: 26113177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of adenocarcinoma and mortality in patients with Barrett's oesophagus diagnosed between 1976 and 1986: implications for endoscopic surveillance.
    Rana PS; Johnston DA
    Dis Esophagus; 2000; 13(1):28-31. PubMed ID: 11005328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of Barrett's adenocarcinoma in an Italian population: an endoscopic surveillance programme. Gruppo Operativo per lo Studio delle Precancerosi Esofagee (GOSPE).
    Ferraris R; Bonelli L; Conio M; Fracchia M; Lapertosa G; Aste H
    Eur J Gastroenterol Hepatol; 1997 Sep; 9(9):881-5. PubMed ID: 9355787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment for Barrett's oesophagus.
    Rees JR; Lao-Sirieix P; Wong A; Fitzgerald RC
    Cochrane Database Syst Rev; 2010 Jan; 2010(1):CD004060. PubMed ID: 20091557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review article: Barrett's oesophagus and carcinoma in Japan.
    Hongo M
    Aliment Pharmacol Ther; 2004 Dec; 20 Suppl 8():50-4. PubMed ID: 15575874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should patients with Barrett's oesophagus be kept under surveillance? The case against.
    Barritt AS; Shaheen NJ
    Best Pract Res Clin Gastroenterol; 2008; 22(4):741-50. PubMed ID: 18656827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review: Barrett's oesophagus in Taiwan.
    Chen PH
    J Gastroenterol Hepatol; 1997 Jun; 12(6):S19-22. PubMed ID: 9195407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of the neoplastic progression of Barrett's oesophagus by endoscopic argon beam plasma ablation.
    Morris CD; Byrne JP; Armstrong GR; Attwood SE
    Br J Surg; 2001 Oct; 88(10):1357-62. PubMed ID: 11578292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barrett's oesophagus: a review of costs of the illness.
    Arguedas MR; Eloubeidi MA
    Pharmacoeconomics; 2001; 19(10):1003-11. PubMed ID: 11735670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolving management of metaplasia and dysplasia in Barrett's epithelium.
    Evans RP; Mourad MM; Fisher SG; Bramhall SR
    World J Gastroenterol; 2016 Dec; 22(47):10316-10324. PubMed ID: 28058012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Surveillance for Barrett's oesophagus: worthwhile?].
    Kastelein F; Kuipers EJ
    Ned Tijdschr Geneeskd; 2012; 156(49):A5497. PubMed ID: 23218039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review article: Barrett's oesophagus and associated adenocarcinoma--a UK perspective.
    Fitzgerald RC
    Aliment Pharmacol Ther; 2004 Dec; 20 Suppl 8():45-9. PubMed ID: 15575873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance in patients with long-segment Barrett's oesophagus: a cost-effectiveness analysis.
    Kastelein F; van Olphen S; Steyerberg EW; Sikkema M; Spaander MC; Looman CW; Kuipers EJ; Siersema PD; Bruno MJ; de Bekker-Grob EW;
    Gut; 2015 Jun; 64(6):864-71. PubMed ID: 25037191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barrett's oesophagus: frequency and prediction of dysplasia and cancer.
    Falk GW
    Best Pract Res Clin Gastroenterol; 2015 Feb; 29(1):125-38. PubMed ID: 25743461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.